VIP152 Is a Novel CDK9 Inhibitor with Efficacy in Chronic Lymphocytic Leukemia

被引：2

作者：

Sher, Steven ^{[1
,2
]}

Beaver, Larry ^{[3
]}

Williams, Katie ^{[3
]}

Orwick, Shelly ^{[3
]}

Walker, Brandi R. ^{[3
]}

Gregory, Charles Thomas ^{[3
]}

Purcell, Matthew ^{[3
]}

Pam, Alexander ^{[4
]}

Yan, Pearlly S. ^{[4
]}

Johnson, Amy J. ^{[5
]}

Frigault, Melanie M. ^{[5
]}

Greer, Joy M. ^{[5
]}

Hamdy, Ahmed ^{[5
]}

Izumi, Raquel ^{[5
]}

Hwang, Stuart ^{[5
]}

Blachly, James S. ^{[3
]}

Byrd, John C. ^{[5
,6
]}

Lapalombella, Rosa ^{[3
]}

机构：

[1] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA

[2] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA

[3] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH 43210 USA

[4] Ohio State Univ, Columbus, OH 43210 USA

[5] Vincerx Pharma Inc, Palo Alto, CA USA

[6] Univ Cincinnati, Dept Internal Med, Coll Med, Cincinnati, OH USA

来源：

关键词：

D O I：

10.1182/blood-2021-153812

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3